David S. Rickman
Papers
1
Total Citations
32
H-Index
1
About
Dr. David S. Rickman is a leading translational researcher in urologic oncology, with a primary focus on prostate cancer genomics and the development of precision biomarkers. His work bridges the critical gap between surgical practice and molecular pathology, particularly through the establishment of high-quality tissue biobanking protocols. His landmark 2011 study, "Biobanking after robotic-assisted radical prostatectomy: a quality assessment of providing prostate tissue for RNA studies" (32 citations), directly addressed a major methodological challenge in the field: the impact of ischemia time on RNA integrity during robotic-assisted laparoscopic radical prostatectomies (RALP). By demonstrating that viable RNA could be reliably extracted from RALP specimens, Dr. Rickman enabled the use of minimally invasive surgical tissue for downstream genomic analyses, a contribution that has shaped modern prostate cancer research infrastructure. His work is foundational for studies correlating molecular signatures with clinical outcomes, and he is recognized for advancing the rigor of tissue-based biomarker discovery. Dr. Rickman’s efforts have empowered researchers to leverage contemporary surgical specimens for high-fidelity transcriptomic studies, directly impacting the reproducibility and translational potential of prostate cancer genomics.
Research Focus
Key Achievements
Top Papers
- 1